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Abstract: Magnetotactic bacteria (MTB) biomineralize intracellular magnetite (Fe3O4) crystals sur-
rounded by a magnetosome membrane (MM). The MM contains membrane-specific proteins that
control Fe3O4 mineralization in MTB. Previous studies have demonstrated that Mms13 is a critical
protein within the MM. Mms13 can be isolated from the MM fraction of Magnetospirillum magneticum
AMB-1 and a Mms13 homolog, MamC, has been shown to control the size and shape of magnetite
nanocrystals synthesized in-vitro. The objective of this study was to use several independent meth-
ods to definitively determine the localization of native Mms13 in M. magneticum AMB-1. Using
Mms13-immunogold labeling and transmission electron microscopy (TEM), we found that Mms13 is
localized to the magnetosome chain of M. magneticum AMB-1 cells. Mms13 was detected in direct
contact with magnetite crystals or within the MM. Immunofluorescence detection of Mms13 in M.
magneticum AMB-1 cells by confocal laser scanning microscopy (CLSM) showed Mms13 localization
along the length of the magnetosome chain. Proteins contained within the MM were resolved by
SDS-PAGE for Western blot analysis and LC-MS/MS (liquid chromatography with tandem mass
spectrometry) protein sequencing. Using Anti-Mms13 antibody, a protein band with a molecular
mass of ~14 kDa was detected in the MM fraction only. This polypeptide was digested with trypsin,
sequenced by LC-MS/MS and identified as magnetosome protein Mms13. Peptides corresponding
to the protein’s putative MM domain and catalytic domain were both identified by LC-MS/MS. Our
results (Immunogold TEM, Immunofluorescence CLSM, Western blot, LC-MS/MS), combined with
results from previous studies, demonstrate that Mms13 and homolog proteins MamC and Mam12,
are localized to the magnetosome chain in MTB belonging to the class Alphaproteobacteria. Because
of their shared localization in the MM and highly conserved amino acid sequences, it is likely that
MamC, Mam12, and Mms13 share similar roles in the biomineralization of Fe3O4 nanocrystals.
Keywords: bacteria; biomineralization; magnetite; magnetotactic; magnetosome; nanocrystal;
protein; TEM
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1. Introduction
Magnetotactic bacteria (MTB) are a group of prokaryotes, which biomineralize mag-
netic crystals of magnetite (Fe3O4) and/or greigite (Fe3S4) surrounded by a lipid-bilayer,
called the magnetosome membrane (MM) [1–4]. The magnetosome membrane (MM)
originates as an invagination of the cytoplasmic membrane creating a vesicle in which
the magnetite crystal nucleates and subsequently grows [5–9]. Proteins associated with
the MM are believed to control the biomineralization of magnetosome crystals [10–21].
Individual magnetosomes are arranged in a chain(s) within a bacterium to maximize the
magnetic dipole moment of the cell therefore allowing MTB to passively align and swim
along Earth’s magnetic field lines [1–4]. Presumably MTB use magnetotaxis in conjunction
with chemotaxis to locate and maintain an optimum position in a water column for growth
and survival [1–4].
Previous studies have shown that the MM contains proteins required for the biogenesis
of intracellular magnetosomes and that the MM appears to be derived from the cytoplasmic
membrane [9,12,13,15–19]. Some of these MM proteins are also found in the cytoplasmic
membrane and fatty acid analysis suggests that the MM is derived from the cytoplasmic
membrane [13,16,19]. Several MM proteins appear to control the formation of the magneto-
some membrane and the biomineralization of the magnetosome crystals [2,6,7,10–17]. For
example, in Magnetospirillum magneticum AMB-1, genomic and proteomic analysis have
identified almost 100 magnetosome specific proteins, and at least a dozen of these proteins
are believed to be involved in magnetosome biomineralization [3,4,16,22].
It has been demonstrated in Magnetospirillum species that several proteins, including
Mms5, Mms6, Mms7 (MamD), Mms12 (MamF) and Mms13 (MamC) are tightly associated
with the MM [3,4,6,9,12–16,18]. To date, inorganic synthesis of magnetite in the presence of
some of these purified proteins has failed to yield crystals that are identical to those found
within the magnetosomes of MTB [17,21]. The morphology of the magnetite crystals in MTB
appears to be strain specific [2–4,23]. This suggests that the mineralization process and the
function of individual proteins may vary by microbial strain. Therefore, it is vital to study
individual proteins in all MTB species to determine similarities and differences between
different bacterial species. There is great interest in understanding the protein-catalyzed
mineralization process involved in magnetosome synthesis and the function of specific MM
proteins in controlling the number, size, and morphology of nascent Fe3O4 nanocrystals.
Among MM proteins, Mms13 and homologous proteins MamC and Mam12, are small
(e.g., Mms13 is 145 amino acids) highly conserved protein within the magnetotactic Al-
phaproteobacteria class and no obvious homologs have been identified in non-magnetotactic
bacteria [3,4,9,12,13,16,18,22]. The secondary structure of MamC (a Mms13 homolog) re-
veals two helicoidal transmembrane domains connected by a α-helix structured loop in the
magnetosome lumen that contains several charged residues predicted to interact with the
magnetite crystal [2–4,11,21,24]. Furthermore, it has been demonstrated that MamC plays
a role in regulating the size and shape of magnetite crystals in MTB [2,4,14,21,25–27] and
in in-vitro mineralization experiments [6,24–27].
Previous studies [12,13,15,16,18,28–32] have employed different methods and tech-
niques to help define the localization of Mms13 and homologous proteins, MamC and
Mam12, in MTB species belonging to the class Alphaproteobacteria. These studies used
several techniques including plasmid-overexpressed fusion proteins, immunogold electron
microscopy, immunofluorescence microscopy, and biochemical and proteomic analysis of
purified cell fractions. Indeed, the use of different methods and techniques to determine
the localization of a protein within a cell is critical to validate results and avoid bias that
can lead to false conclusions.
The objective of this study was to use multiple independent methods on the same
organism (M. magneticum AMB-1) to determine the subcellular location of native Mms13
with micron to nanometer scale resolution. We used (1) protein fractionation followed by
Western blot analysis, (2) LC-MS/MS protein sequencing, (3) immunogold-Mms13 labeling
followed by transmission electron microscopy (TEM) of cells, and (4) immunofluorescence
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detection of Mms13 by confocal laser scanning microscopy (CLSM) on whole cells. To
our knowledge, this is the first time that immunogold TEM and immunofluorescence
microscopy have be used to examine the localization of native Mms13 in M. magneticum
AMB-1 cells and purified magnetosomes. This work provides for a more complete un-
derstanding of the subcellular localization of homologous proteins MamC, Mam12, and
Mms13 in members of the magnetotactic Alphaproteobacteria group. This information is
important to understanding protein function and identifying shared biomineralization
pathways among MTB.
2. Materials and Methods
To purify magnetosomes and prepare cell soluble and membrane fractions of M. mag-
neticum AMB-1 (ATCC 700264), the protocol described in [33] was followed. To clone
mms13 (amb0951 in M. magneticum AMB-1; [22]), genomic DNA from M. magneticum AMB-
1 was obtained from the American Type Culture Collection (ATCC #700264). The gene
amb0951 was amplified by the polymerase chain reaction (PCR) with the primers: fw1
(5′-CACCATGCGCTCCTGGCTG-3′) and rev2 (5′-TCAGGCCAGTTCGTCCCGC-3′). The
PCR product was cloned into pET160/GW/D-TOPO according to the manufacturer’s
instructions (Invitrogen, Carlsbad, CA, USA). PCR products and the vector containing
mms13 (pET160/GW/D-TOPO/mms13) were sequenced at the Plant-Microbe Genomics
Facility at The Ohio State University.
Escherichia coli TOP10 (Invitrogen, Carlsbad, CA, USA) and E. coli BL21 (Invitrogen,
Carlsbad, CA, USA) cells were used for protein expression. Cells were cultured in 250 mL of
Luria broth (LB) at 37 ◦C and induced with 1 mM isopropyl-1-thio-β-D galactopyranoside
for 5.5 h. The recombinant Mms13 protein (rMms13) was insoluble and found in inclusion
bodies. Therefore, 8 M urea was used to solubilize the inclusion bodies and rMms13 was
purified under denaturing conditions using a nickel-nitrilotriacetic acid column (Qiagen,
Hilden, Germany). rMms13 was renatured at 4 ◦C by dialysis against 1 L of buffer contain-
ing 0.02 M Tris-HCl, 5 M NaCl, and 1 mM phenylmethanesulfonylfluoride (PMSF), pH 7.5.
This buffer also contained 4 M, 2 M, 1 M, and 0.5 M urea for 2 h each. The final dialysis was
performed overnight at 4 ◦C in 1 L of buffer without urea. The protein was dialyzed several
more times for 3 h each, at 4 ◦C against 1 L of fresh buffer (0.02 M Tris-HCl, 0.5 M NaCl,
pH 7.5). This was the rMms13-protein fraction that was used for antibody production.
To determine that the purified recombinant protein was indeed rMms13, the final
protein fraction was resolved by SDS-PAGE and stained with Coomassie R-250. The
protein band corresponding to the molecular mass of rMms13 was excised and subjected
to peptide mass fingerprinting at the Mass Spectrometry & Proteomics Facility at The Ohio
State University.
Polyclonal antibodies against rMms13 were produced in a rabbit by ProSci Incorpo-
rated (Poway, CA, USA). The final concentration of the antibody (anti-Mms13) determined
by direct ELISA was 1.4 mg/mL. These antibodies were used for Western blot and im-
munogold labeling. Pre-immune serum was removed from the rabbit before injecting
with antigen (rMms13) into the rabbit, which was later used as a control for immunogold
labeling. For the Western blots, the protocol described in [33] was followed, using anti-
Mms13 antibody (1:50,000) as primary antibody and goat anti-rabbit HRP (horseradish
peroxidase) antibody (1:200) as secondary antibody and the Clean-Blot IP Detection Kit
HRP (Thermo-Pierce, Rockford, IL, USA). PVDF membrane (Invitrogen) was blocked with
5% BSA, imaged using a Kodak Gel Logic 1500 Imager (Rochester, New York, NY, USA)
and image processing (i.e., exposure, contrast) was applied to every pixel of the image
using Adobe Photoshop.
For protein identification, protein bands were excised from polyacrylamide gel, di-
gested with trypsin and sequenced by liquid chromatographic tandem mass spectrometry
(LC-MS/MS). Protein identification was performed by staff at The Ohio State University,
Mass Spectrometry & Proteomics Facility. Proteins with a Mascot score of 50 or higher and
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a minimum of two unique peptides from one protein with a -b or -y ion sequence tag of
five residues or better were accepted.
TEM grid preparation and immunogold labeling experiments of M. magneticum AMB-
1 cells and purified magnetosomes were done following the procedure described in [33,34].
Cells were placed on a TEM grid and incubated first with anti-Mms13 (1:2000), and second
with goat anti-rabbit IgG antibody conjugated with 10 nm gold (Sigma-Aldrich, St. Louis,
MO, USA) diluted 1:100 in 0.5% BSA in Tris-HCl. Purified magnetosomes (1:1250 diluted)
were incubated with anti-Mms13 diluted 1:4000 and goat anti-rabbit IgG antibody (1:100)
conjugated with 10 nm colloidal gold (Sigma-Aldrich, St. Louis, MO, USA).
Fluorescence CLSM of whole, intact M. magneticum AMB-1 cells was performed
as described by Oestreicher et al., 2016 [33,34]. Cells were harvested by centrifuging at
10,000× g for 10 min at 4 ◦C and fixed in 4% paraformaldehyde for 5 min, placed on a glass
slide and washed with PBS (phosphate buffered saline, pH 7.4). Cells were incubated and
labeled with primary antibody (Anti-Mms13) at 1:400 dilution for 1 h at room temperature.
Cells were washed 3X with PBS and labeled with secondary antibody, goat anti-rabbit
IgG antibody conjugated to DyLight 488 (1:100; Thermo Fisher Scientific, Waltham, MA,
USA). Cells were washed with PBS and analyzed using an Olympus FV 1000 CLSM
(Olympus Corporation).
3. Results
Cloning the PCR product into the pET160/GW/D-TOPO vector yielded a heterol-
ogous expressed protein (rMms13), which preferentially accumulated in E. coli cells as
inclusion bodies and had to be solubilized and purified using urea. The urea was removed
and rMms13 renatured by extensive dialysis. The maximal yield in total protein, moni-
tored by SDS-PAGE, was achieved using BL21 CodonPlus E. coli cells, under the following
induction conditions: 1 mM IPTG, at 37 ◦C for 5.5 h.
The rMms13 protein was purified and renatured by extensive dialysis in buffer contain-
ing progressively less urea until the dialysis buffer contained no urea. The molecular mass
of rMms13 was found to be approximately 18 kDa by SDS-PAGE (Figure 1) corresponding
to the expected size of the Mms13 protein (~14.5 kDa) plus an additional ~4 kDa resulting
from the pET160 vector. The ~18 kDa Coomassie-stained protein band (Figure 1, lane 3)
was identified using LC-MS/MS. The polypeptide was found to correspond (p < 0.05) to
the Mms13 protein from M. magneticum AMB-1.
Figure 1. SDS-PAGE gel of purified recombinant Mms13 (rMms13) stained with Coomassie R-250.
The lanes correspond to 10 µg of protein from non-induced Escherichia coli cells (lane 1), 10 µg
of protein from induced E. coli cells (lane 2), and 5 µg of rMms13 protein purified using IMAC
(lane 3). The black arrow shows the protein band that was excised from the gel, digested with trypsin,
sequenced using LC-MS/MS to confirm its identity as rMms13. The positions and molecular masses
(in kilodaltons) of protein standards are indicated at the left (lane M).
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Western blot analysis was performed to determine whether Mms13 was present in the
soluble fraction, cytoplasmic membrane fraction, or magnetosome membrane fraction of
M. magneticum AMB-1. A band corresponding to the expected molecular mass of Mms13
(~14.5 kDa) was only present in the magnetosome membrane fraction (Figure 2b, lane 3;
Figure S1). No band was observed in the soluble fraction (Figure 2b, lane 1). No band was
observed in the cytoplasmic membrane fraction (Figure 2b, lane 2).
Figure 2. (a) Coomassie R-250 stained protein fraction of M. magneticum AMB-1 as resolved by
SDS-PAGE. (b) Western blot of proteins solubilized from different fractions of M. magneticum AMB-1,
resolved by SDS-PAGE and incubated with anti-Mms13 antibody. Lanes correspond to 10 µg soluble
proteins (lane 1), 10 µg of cytoplasmic membrane proteins (lane 2), and 10 µg of magnetosome
membrane proteins (lane 3). For comparison, molecular weight markers (lane M) were also resolved
by SDS-PAGE. The positions and molecular masses (in kilodaltons) of protein standards are indicated
using numbers down the left-side of the gel. The black arrow shows protein band that was excised,
digested with trypsin and identified by LC-MS/MS peptide sequencing. (c) Mms13 amino acid
sequence and locations of the four peptides that were identified by LC-MS/MS (numbered 1–4,
red-colored, bold font that is highlighted and underlined). Mms13 was not detected by LC-MS/MS
peptide sequencing in lanes 1 or 2.
This ~14 kDa band (Figure 2b, lane 3, black arrow) was excised from a polyacrylamide
gel, digested with trypsin, and its amino acid sequence determined by LC-MS/MS. Four
peptides were isolated and their amino acid sequences are shown in Figure 2c. LC-MS/MS
analysis identified the ~14 kDa protein band contained within the magnetosome membrane
fraction as the 145 amino acid magnetic particle protein Mms13 from Magnetospirillum
magneticum AMB-1 (Figure 2c). Gel slices from lanes 1 and 2 (Figure 2), corresponding to
~14 kDa were excised and subjected to in-gel trypsin digestion followed by LC-MS/MS.
Peptides corresponding to Mms13 were not detected by LC-MS/MS for the soluble fraction
(Figure 2, lane 1) or for the cytoplasmic membrane fraction (Figure 2, lane 2).
TEM analysis showed that the M. magneticum AMB-1 cells displayed Mms13 labeling
along the magnetosome chain (Figure 3a–c). The nanogold particles were either detected
within the matrix surrounding the magnetosomes or directly touching the Fe3O4 crystal
(Figure 3d–f). It was also observed that some labeling appeared to occur distal to the Fe3O4
particles but typically nanogold particles were found to be in-line with the magnetosome
chain (Figure 3a–c). In many instances, we observed that individual magnetosome particles
were coated with numerous nanogold particles (Figure 3d–f). No nanogold labeling of
the magnetosome chain was observed in either negative control when substituting 0.5%
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BSA for primary antibody (Figure 3g) or when 5% pre-immune serum was used in place of
anti-Mms13 (Figure 3h).
Figure 3. Ultrathin sections of M. magneticum AMB-1. (a–c) A single cell showing magnetosomes labeled with Mms13
antibody and then labeled with goat anti-rabbit antibody conjugated with 10 nm colloidal gold. (b) Three individual
magnetosome particles showing multiple bound nanogold particles. (d–f) Magnetosome chain from M. magneticum AMB-1
cells showing nanogold particles bound directly to magnetosome crystal or observed within magnetosome membrane.
(g) Negative control for immunolabeling showing an ultrathin section of M. magneticum AMB-1 treated exactly as in (a),
but with 0.5% BSA substituted in place of the primary antibody. (h) Negative control treated exactly as in (a) but with 5%
pre-immune serum substituted in place of the primary antibody. Dotted gray line (shown in a–c,g,h) is outline of bacterium.
Scale bars provided for each image. Magnetosomes are large (i.e., ~70 nm) black particles arranged in a linear chain. Several
individual magnetosomes are indicated with dotted black arrow and labeled Fe3O4. Colloidal gold particles are very small
(i.e., ~10 nm) black spheres. Several individual nanogold particles are indicated with solid black arrow and labeled Au.
Immunofluorescence of Dylight 488 tagged Anti-Mms13 allowed for the detection
and localization of Mms13 within intact M. magneticum AMB-1 cells by CLSM coupled
with Nomarski interference contrast technique. Mms13-labeling was observed only along
the magnetosome chain of M. magneticum AMB-1, occurring in the center and along the
long axis of each cell (Figure 4d). No fluorescence labeling occurred distal to the long
axis of each cell (Figure 4). Negative controls were conducted on M. magneticum AMB-1
cells using buffer that lacked primary antibody (i.e., Anti-Mms13) or lacked secondary
antibody (i.e., goat anti-rabbit IgG antibody conjugated to DyLight 488). No fluorescence
was observed in these two control experiments.
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Figure 4. Fluorescent labeled Magnetospirillum magneticum AMB-1 cells using Anti-Mms13 (1:400) as the primary antibody
and goat anti-rabbit Dylight 488 (1:100) as the secondary antibody. (a) Nomarski image of M. magneticum AMB-1 cells.
(b) The same view field as (a) showing only fluorescent image. (c) Merged Nomarski and fluorescent images showing the
outline of M. magneticum AMB-1 cells with green fluorescent tag along the major axis of the cells co-localized with the
magnetosome chain. (d) Enlargement of view field shown in previous three panels. White arrow in each panel identifies the
same cell. Scale bars provided in each panel.
4. Discussion
As shown in Table 1, previous reports have employed different methods to help define
the localization of Mms13 and its homologs, MamC and Mam12, in four MTB species
belonging to the class Alphaproteobacteria. In M. gryphiswaldense and M. magneticum AMB-1,
the localization of MamC and Mms13, was examined using an inducible expression plasmid
to overexpress recombinant GFP-MamC fusion protein in MTB and examine cells and
purified magnetosomes using fluorescence microscopy and spectroscopy [28,29]. Similar
studies have not yet been employed on Mam12 in M. magnetotacticum MS-1 or on MamC in
M. marinus MC-1. In other reports, immunogold labeling TEM of whole cells and purified
magnetosomes was done with M. magnetotacticum MS-1 and M. marinus MC-1 [18,30].
Immunogold labeling TEM has not yet been conducted for MamC in M. gryphiswaldense or
Mms13 in M. magneticum AMB-1.
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Table 1. Studies conducted to examine subcellular localization of homologous proteins MamC, Mam12 and Mms13 in MTB






















Recombinant MamC-GFP No No [28,35,37,39] [28] [28,38] [28]
Genome Expression







No [31] [29,32] [29,31,36] [29,31] [31]
Genome Expression




Recombinant Mam12-GFP No No No No No No
Genome Expression




Recombinant MamC-GFP No No No No No No
Genome Expression
Native MamC [30] [30] No No [30] [30]
[Number] citation for journal article where experiment was published. The word “No” indicates that no studies have been published for
this method of localization. ‡ Experiments that were completed and reported here in our study. AA, Amino Acid. GFP, Green Fluorescent
Protein. MTB, Magnetotactic Bacteria. MM, Magnetosome Membrane. TEM, Transmission Electron Microscopy. SDS-PAGE, Sodium
Dodecyl Sulfate Polyacrylamide Gel Electrophoresis, Two-Dimensional Gel Electrophoresis. TSHR, thyroid-stimulating hormone receptor.
In addition to microscopy, biochemical and proteomic analysis of the magnetosome
membrane has been conducted on MamC, Mam12 and Mms13 in all four magnetotac-
tic Alphaproteobacteria (Table 1) [12,13,15,16,18,28–32,35–40]. MamC is a highly conserved
protein and one of the most abundant magnetosome-associated proteins [14,30]. When
extracted from the cell, MamC, Mam12 and Mms13 have been found to associate with the
MM fraction [12,13,15,16,18]. In-vivo genetic studies demonstrated that MamC regulates
the size of magnetosome crystals in M. gryphiswaldense [14]. In-vitro biomineralization
experiments using recombinant MamC demonstrated that MamC plays a role in controlling
the size and shape of magnetite crystals in Magnetococcus marinus strain MC-1 [21,24,26].
By establishing the location of MamC, Mam12, and Mms13 within a bacterium and
relative to the magnetosome chain, we gain significant insight into if and how these pro-
teins function to control the mineralization of Fe3O4 nanocrystals within the magnetosome.
Consequently, this information is important for the in-vitro synthesis of Fe3O4 nanocrystals
in the presence of purified proteins [15]. Moreover, establishing the subcellular localization
of these three homologous proteins in members of the magnetotactic Alphaproteobacteria
group allows for a better understanding of protein function and helps to identify shared
biomineralization pathways among MTB (Table 1). Using immunogold stained ultrathin
sections of bacterial cells and purified magnetosomes, native Mam12 was found to be local-
ized to the magnetosome membrane of M. magnetotacticum [18]. Recombinant MamC-GFP
was detected within the magnetosome chain of M. gryphiswaldense using immunoblotting
and fluorescence microscopy [28]. In addition, finally, immunogold labeling combined
with TEM, showed that MamC was localized exclusively to the magnetosome chain of M.
marinus strain MC-1 [30].
Previous studies, as summarized in Table 1, provide compelling, but not conclusive
evidence, for the localization of Mms13 in M. magneticum AMB-1. Arakaki et al., 2003
conducted experiments with M. magneticum AMB-1, where they extracted proteins tightly
bound to magnetic particles using 1% SDS (sodium dodecyl sulfate), separated them
by two-dimensional gel electrophoresis and sequenced the stained proteins by Edman
degradation [15]. They identified four proteins that were tightly bound to the purified
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magnetic particles including Mms13 [15]. Tanaka et al., 2006 conducted similar proteomic
analysis of MM fractions isolated from M. magneticum AMB-1 [16]. They identified a total
of 78 proteins associated with the MM fraction, including Mms13 [16].
Yoshino and Matsunaga, 2006 [31], Yoshino et al., 2010 [29], and Yoshino et al., 2021 [36]
used a tetracycline-controlled inducible expression plasmid for M. magneticum AMB-1,
using Mms13 as an anchor protein, to overexpress heterologous proteins, including green
fluorescent protein (GFP, molecular mass ~27 kDa), on the surface of magnetic particles. The
plasmid containing mms13-GFP was overexpressed in M. magneticum AMB-1 and magnetic
particles were extracted and collected from lysed M. magneticum AMB-1 cells using a
neodymium-boron (Nd-B) magnet [29,31]. Yoshino et al., 2010 [29] used fluorescence
spectroscopy to demonstrate that magnetosomes extracted from M. magneticum AMB-1
were coated with the recombinant Mms13-GFP fusion protein [29]. M. magneticum AMB-1
cells transformed with a tetracycline-inducible Mms13-GFP plasmid were also observed by
fluorescence microscopy in the presence of anhydrotetracycline hydrochloride [29]. Yoshino
and Matsunaga, 2006 [31] and Yoshino et al., 2010 [29] expressed two other recombinant
Mms-13 fusion proteins (i.e., Mms13-Luciferase [31] and Mms13-FLAG-CD81 [29]) in
M. magneticum AMB-1. They extracted the proteins from purified magnetic particles using
1% SDS and determined that both Mms13-Luciferase and Mms13-FLAG-CD81 fusion
proteins were found attached to the magnetic particles using Western blotting and anti-
luciferase antibody or anti-FLAG antibody [29,31]. Quinlan et al., 2011 [32] also developed
an inducible plasmid expression system that used IPTG (isopropylthio-β-galactoside) to
overexpress recombinant Mms13-GFP in M. magneticum AMB-1. When the mms13-GFP
was overexpressed in M. magneticum AMB-1 and visualized by fluorescence microscopy,
green fluorescence was observed along the length of the cell [32].
The previous studies [15,16,29,31,32,36] on Mms13 expression and localization in
M. magneticum AMB-1 (Table 1) focused on two types of experiments: (1) the use of fluores-
cence microscopy and spectroscopy or enzyme activity to examine plasmid-overexpressed
recombinant fusion proteins (i.e., Mms13-GFP, Mms13-FLAG-CD81, Mms13-Luciferase,
Mms13-TSHR) and (2) cellular fractionation, purification of MM proteins, followed by
amino acid sequencing or enzyme assays. While important, these experiments have limita-
tions. For example, previous studies have demonstrated that fusion proteins can perturb a
native protein’s activity, expression, function, and localization [41–44]. In Yoshino et al.,
2010 [29], Yoshino and Matsunaga, 2006 [31], Quinlan et al., 2011 [32] and Yoshino et al.,
2021 [36] an inducible plasmid expression system was used in M. magneticum AMB-1 to
overexpress comparatively large non-native proteins (i.e., GFP is ~27 kDa; CD81 is ~25 kDa;
Luciferase is ~61kDa; TSHR, thyroid-stimulating hormone receptor is ~87 kDa) fused to the
much small native Mms13 protein (i.e., Mms13 is ~12 kDa). The considerably larger size of
the non-native protein (e.g., GFP is twice as large as Mms13, Luciferase is five-times larger
than Mms13, TSHR is seven-times larger than Mms13) has steric consequences for protein
folding, function and targeting that could alter expression and/or localization of the native
protein [41–44]. In addition, the resolution limit of conventional fluorescence microscopy
is approximately 250 nm due to its dependance on the wavelength of the excitation light
and microscope optics. This presents a challenge when imaging magnetosome particles,
which are approximately 2–6 times smaller than the resolution offered by fluorescence
microscopy. The spatial resolution of the M. magneticum AMB-1 fluorescence images pro-
vided in Yoshino et al., 2010 [29] and Quinlan et al., 2011 [32] was not sufficient to resolve
magnetosome particles contained within the bacteria. TEM, on the other hand, which was
conducted as part of our study on M. magneticum AMB-1, is ideally suited for obtaining the
nm resolution required to image individual magnetosomes and Mms13 molecules within
a bacterium.
In the present study, we used Western blot analysis, LC-MS/MS protein sequencing,
immunofluorescence microscopy, and immunogold labeling TEM to establish the subcellu-
lar location of native Mms13 in M. magneticum AMB-1. Western blot analysis showed that
a polypeptide with a molecular mass similar to Mms13 (~14.5 kDa) was present in the MM
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fraction of M. magneticum AMB-1 (Figure 2b, lane 3). This ~14.5 kDa polypeptide was not
detected in either the soluble fraction or cytoplasmic membrane fraction (Figure 2b, lanes 1
and 2). To determine the identity of this protein, LC-MS/MS peptide sequence analysis was
performed on the protein band observed in the MM fraction (Figure 2b, lane 3, black arrow).
LC-MS/MS analysis matched four peptides to Mms13 (Figure 2c). Peptide 1 was from
the N-terminal end of Mms13 and peptides 2–4 were from the C-terminal end of Mms13
(Figure 2c). These results show that the mature Mms13 protein in M. magneticum AMB-1
contains at the very least amino acid residues 33–145 (Figure 2c). Thus, the mature Mms13
protein in M. magneticum AMB-1 contains both its hydrophobic, N-terminal putative mag-
netosome membrane domain and its hydrophilic, C-terminal putative catalytic domain.
These results are consistent with Arakaki et al., 2003 [15] and Tanaka et al., 2006 [16], which
showed that Mms13 could be extracted from purified magnetosomes.
Western blot analysis and LC-MS/MS protein identification agreed with TEM analysis
of M. magneticum AMB-1 (Figure 3). Immunogold electron microscopy showed Mms13
labeling along a bacterium’s magnetosome chain (Figure 3a–c). Nanogold particles were ob-
served to be directly touching the Fe3O4 particles, within the magnetosome membrane sur-
rounding the Fe3O4 particles or very close (<10 nm) to the magnetosome chain (Figure 3a–c).
In many instances, multiple nanogold particles were found to be attached to a single mag-
netosome crystal (Figure 3d–f). For example, in Figure 3f, we see a binding ratio of 3:1
(gold particle to magnetosome particle), with all nanogold particles touching or <10 nm
from a magnetosome. These observations indicated that there was a strong affinity of the
Anti-Mms13-nanogold-label for the magnetosome chain.
Control experiments were also performed using 5% pre-immune serum and no pri-
mary antibody to confirm the specificity of Anti-Mms13 antibody for Mms13 (Figure 3h).
The pre-immune serum does not contain antibodies for Mms13 and thus nanogold par-
ticles should not be detected in TEM images using pre-immune serum. Occasionally a
small number of nanogold particles were observed outside the bacterial cell; however,
no nanogold labeling occurred within or near the magnetosome chain (Figure 3g,h). This
confirmed that the results were not due to background labeling by the secondary antibody.
Fluorescence microscopy was used to confirm the TEM analysis, which showed
Mms13 localized to the MM and magnetite crystal surface. CLSM revealed fluorescently
labeled Mms13 molecules along the major axis of the bacterium (Figure 4). Green fluores-
cence DyLight 488 molecules were observed co-localized with the magnetosome chain
(Figure 4). No fluorescent labeling was observed outside the bacteria or distal to the mag-
netosome chain (Figure 4). Thus, our fluorescence measurements were consistent with
TEM analysis that showed native Mms13 molecules localized to the magnetosome chain of
M. magneticum AMB-1. These results were also consistent with our biochemical analyses
that used LC-MS/MS and Western blotting to identify native Mms13 molecules within the
MM fraction M. magneticum AMB-1.
5. Conclusions
Defining the localization of magnetosome proteins in MTB is a necessary step in
determining their function(s) in magnetosome biomineralization. By understanding the
mineralization process of Fe3O4 crystals in all MTB we can better understand the evolution
of magnetotaxis and learn to reproduce the synthesis of Fe3O4 nanocrystals in-vitro. Such
information could be explored in attempts to obtain tailored Fe3O4 magnets with specific
morphology and size. By combining the results presented here with previous [12–16,18,21,
24,26–32,35–40], we can definitively conclude that homologous proteins MamC, Mam12,
and Mms13 are localized to the magnetosome chain of all magnetotactic Alphaproteobacteria
where the proteins likely function in the biomineralization of Fe3O4 nanocrystals.
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Supplementary Materials: The following are available online at https://www.mdpi.com/article/10
.3390/cryst11080874/s1, Figure S1. This Western blot is the same Western blot shown in Figure 2b,
except that this image has not been modified (e.g., contrast, exposure, brightness) using image
processing software (i.e., Adobe Photoshop). Lanes correspond to 10 µg soluble proteins (lane 1),
10 µg of cytoplasmic membrane proteins (lane 2), and 10 µg of magnetosome membrane proteins
(lane 3). For comparison, molecular weight markers (lane M) are provided with the molecular masses
(in kilodaltons) of protein standards indicated using numbers down the left-side of the gel. The black
arrow shows protein band corresponding to Mms13.
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